mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.5 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.035 |
0.6 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |